SB 853 · 2021-22
Limits insurers' ability to cut prescribed drug coverage
Official subject Prescription drug coverage.
Didn't pass Passed Senate, stopped in Assembly · Held in committee
Plain-language summary
Bars health plans and insurers from limiting coverage of a drug, dose, or dosage form as prescribed, or adding cost sharing, when certain criteria apply. Cutting or ending an approved ongoing treatment counts as an adverse benefit determination and requires written notice at least 7 days ahead. Plans must keep covering approved ongoing treatment during an appeal.
Official summary · Legislative Counsel's Digest
Describes the final version (Amended Assembly, June 2, 2022).
Read the official summary (4 paragraphs)
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of disability insurers, including health insurers, by the Department of Insurance. Existing law generally authorizes a health care service plan or health insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. Existing law prohibits a health care service plan contract that covers prescription drug benefits or a specified health insurance policy from limiting or excluding coverage for a drug on the basis that the drug is prescribed for a use that is different from the use for which it was approved by the federal Food and Drug Administration if specified conditions are met. Existing law also prohibits a health care service plan that covers prescription drug benefits from limiting or excluding coverage for a drug that was previously approved for coverage if an enrollee continues to be prescribed that drug, as specified.
This bill would expand the above-described prohibitions to prohibit limiting or excluding coverage of a drug, dose, or dosage form, and would apply the prohibition to blanket disability insurance policies and certificates. The bill would prohibit a health care service plan or disability insurer that provides coverage for prescription drugs from limiting or declining to cover a drug or dose of a drug as prescribed, or imposing additional cost sharing for covering a drug as prescribed, if specified criteria apply. The bill would provide that a reduction or termination of an ongoing and approved course of treatment before the end of the treatment or the end or amendment of the policy is an adverse benefit determination, and would require a health care service plan or disability insurer to notify an enrollee or insured, or their representative, and the enrollee’s or insured’s provider in writing of the adverse benefit determination no fewer than 7 calendar days before the effective date. The bill would require a plan or insurer that has approved an ongoing course of treatment to provide continuing coverage pending appeal or review. Because a willful violation of the bill’s requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Official title
An act to amend Sections 1367.21 and 1367.22 of, and to add Sections 1367.26 and 1367.28 to, the Health and Safety Code, and to amend Section 10123.195 of, and to add Sections 10123.134 and 10123.190 to, the Insurance Code, relating to health care coverage.
Timeline
- Jan. 19, 2022 Introduced
- May 25, 2022 Passed Senate 39 yes, 0 no
- Aug. 11, 2022 Stopped in the Assembly Held in committee
Full official history (23 actions)
- Jan. 19, 2022 Introduced: Introduced. Read first time. To Com. on RLS. for assignment. To print.
- Jan. 20, 2022 From printer. May be acted upon on or after February 19.
- Jan. 26, 2022 Referred to Com. on HEALTH.
- Feb. 7, 2022 Art. IV. Sec. 8(a) of the Constitution dispensed with.
- Feb. 7, 2022 (Ayes 31. Noes 6.)
- Feb. 7, 2022 Joint Rule 55 suspended. (Ayes 31. Noes 6. Page 2880.)
- Feb. 28, 2022 From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
- March 29, 2022 Set for hearing April 20.
- April 21, 2022 From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 10. Noes 0. Page 3461.) (April 20).
- April 25, 2022 Read second time and amended. Re-referred to Com. on APPR.
- April 29, 2022 Set for hearing May 9.
- May 9, 2022 May 9 hearing: Placed on APPR suspense file.
- May 13, 2022 Set for hearing May 19.
- May 19, 2022 From committee: Do pass. (Ayes 7. Noes 0. Page 3771.) (May 19).
- May 19, 2022 Read second time. Ordered to third reading.
- May 23, 2022 Ordered to special consent calendar.
- May 25, 2022 Passed Senate: Read third time. Passed. (Ayes 39. Noes 0. Page 3928.) Ordered to the Assembly.
- May 26, 2022 In Assembly. Read first time. Held at Desk.
- June 2, 2022 Referred to Com. on HEALTH.
- June 2, 2022 From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
- June 29, 2022 From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (June 28). Re-referred to Com. on APPR.
- Aug. 3, 2022 August 3 set for first hearing. Placed on suspense file.
- Aug. 11, 2022 August 11 hearing: Held in committee and under submission.